01 2AbbVie Corporation
02 8Allergan Inc.
03 2Bausch Health, Canada Inc.
04 2Galderma Canada Inc.
05 1Gowling WLG (Canada) LLP
Patent Expiration Date : 2014-09-19
Date Granted : 2006-05-02
Brand Name : ALPHAGAN
Patent Number : 2173974
Filing Date : 1994-09-19
Strength per Unit : 0.20%
Dosage Form : Ophthalmic Solution
Human Or VET : Human
Route of Administration : Topical, ocular
Patent Expiration Date : 2014-09-19
Date Granted : 2006-05-02
Patent Expiration Date : 2016-06-17
Date Granted : 2002-09-03
Brand Name : ALPHAGAN
Patent Number : 2225626
Filing Date : 1996-06-17
Strength per Unit : 0.20%
Dosage Form : Ophthalmic Solution
Human Or VET : Human
Route of Administration : Topical, ocular
Patent Expiration Date : 2016-06-17
Date Granted : 2002-09-03
Patent Expiration Date : 2014-09-19
Date Granted : 2006-05-02
Brand Name : ALPHAGAN
Patent Number : 2173974
Filing Date : 1994-09-19
Strength per Unit : 0.50%
Dosage Form : Ophthalmic Solution
Human Or VET : Human
Route of Administration : Topical, ocular
Patent Expiration Date : 2014-09-19
Date Granted : 2006-05-02
Patent Expiration Date : 2016-06-17
Date Granted : 2002-09-03
Brand Name : ALPHAGAN
Patent Number : 2225626
Filing Date : 1996-06-17
Strength per Unit : 0.50%
Dosage Form : Ophthalmic Solution
Human Or VET : Human
Route of Administration : Topical, ocular
Patent Expiration Date : 2016-06-17
Date Granted : 2002-09-03
Patent Expiration Date : 2014-09-19
Date Granted : 2006-05-02
Brand Name : ALPHAGAN P
Patent Number : 2173974
Filing Date : 1994-09-19
Strength per Unit : 0.15%
Dosage Form : Ophthalmic Solution
Human Or VET : Human
Route of Administration : Topical, Ocular
Patent Expiration Date : 2014-09-19
Date Granted : 2006-05-02
Patent Expiration Date : 2016-06-17
Date Granted : 2002-09-03
Brand Name : ALPHAGAN P
Patent Number : 2225626
Filing Date : 1996-06-17
Strength per Unit : 0.15%
Dosage Form : Ophthalmic Solution
Human Or VET : Human
Route of Administration : Topical, Ocular
Patent Expiration Date : 2016-06-17
Date Granted : 2002-09-03
Patent Expiration Date : 2023-04-09
Date Granted : 2005-10-25
Brimonidine Tartrate, Timolol Maleate
Brand Name : COMBIGAN
Patent Number : 2440764
Filing Date : 2003-04-09
Strength per Unit : 0.2% / 0.5%
Dosage Form : Ophthalmic Solution
Human Or VET : Human
Route of Administration : Topical,Opthalmic
Patent Expiration Date : 2023-04-09
Date Granted : 2005-10-25
Patent Expiration Date : 2014-09-19
Date Granted : 2006-05-02
Brimonidine Tartrate, Timolol Maleate
Brand Name : COMBIGAN
Patent Number : 2173974
Filing Date : 1994-09-19
Strength per Unit : 0.2% / 0.5%
Dosage Form : Ophthalmic Solution
Human Or VET : Human
Route of Administration : Topical,Opthalmic
Patent Expiration Date : 2014-09-19
Date Granted : 2006-05-02
Patent Expiration Date : 2020-01-04
Date Granted : 2009-08-04
Brimonidine Tartrate, Timolol Maleate
Brand Name : COMBIGAN
Patent Number : 2357014
Filing Date : 2000-01-04
Strength per Unit : 0.2% / 0.5%
Dosage Form : Ophthalmic Solution
Human Or VET : Human
Route of Administration : Topical,Opthalmic
Patent Expiration Date : 2020-01-04
Date Granted : 2009-08-04
Patent Expiration Date : 2016-06-17
Date Granted : 2002-09-03
Brimonidine Tartrate, Timolol Maleate
Brand Name : COMBIGAN
Patent Number : 2225626
Filing Date : 1996-06-17
Strength per Unit : 0.2% / 0.5%
Dosage Form : Ophthalmic Solution
Human Or VET : Human
Route of Administration : Topical,Opthalmic
Patent Expiration Date : 2016-06-17
Date Granted : 2002-09-03
